BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Pharm Country

  Mylan Launches Generic Fenoglide Tablets

  July 6, 2016

   · 

  1 min read
• Drug Development

  AnaptysBio Initiates Multiple Ascending Dose Cohorts In ANB020 Phase 1 Clinical Trial

  July 6, 2016

   · 

  2 min read
• FDA

  Luminex Snags FDA Clearance and CE-IVD Mark for the ARIES M1 System

  July 6, 2016

   · 

  5 min read
• Business

  RiboMed Biotechnologies, Inc. And Tocagen Inc. Collaborate To Analyze Epigenetic Prognostic Markers, Including MGMT, In Recurrent Brain Tumors

  July 6, 2016

   · 

  5 min read
• Drug Development

  Bausch & Lomb And Nicox Announce The Publication Of Latanoprostene Bunod Ophthalmic Solution 0.024% Phase 3 Study Results In American Journal Of Ophthalmology

  July 6, 2016

   · 

  9 min read
• Deals

  PDL BioPharma Closes Equity Investment Transaction In Noden Pharma For The Acquisition Of Tekturna (Aliskiren) And Tekturna HCT (Aliskiren And Hydrochlorothiazide)

  July 6, 2016

   · 

  6 min read
• Business

  Initiation Of Phase 1 Clinical Study With Novel Immuno-Oncology Candidate Triggers US$10 Million Milestone Payment From AstraZeneca PLC

  July 6, 2016

   · 

  3 min read
• Policy

  Clinical Study Discusses The Value Of C4 Imaging’s Sirius Positive-Signal MRI Marker In MRI-Guided Prostate Cancer Treatment

  July 6, 2016

   · 

  2 min read
• Business

  Leslie Heisz Appointed To Edwards Lifesciences Board Of Directors

  July 6, 2016

   · 

  1 min read
• Business

  West Pharmaceutical Services Announces Quarterly Dividend

  July 6, 2016

   · 

  1 min read